zolpidem tartrate

FDA Drug Profile — ZOLPIDEM TARTRATE, Ambien, zolpidem tartrate, Ambien CR, Zolpidem Tartrate

Drug Details

Generic Name
zolpidem tartrate
Brand Names
ZOLPIDEM TARTRATE, Ambien, zolpidem tartrate, Ambien CR, Zolpidem Tartrate
Application Number
ANDA077903
Sponsor
Proficient Rx LP
NDC Codes
49
Dosage Forms
TABLET, TABLET, FILM COATED, TABLET, COATED, TABLET, FILM COATED, EXTENDED RELEASE, CAPSULE
Routes
ORAL, SUBLINGUAL
Active Ingredients
ZOLPIDEM TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE AMBIEN (zolpidem tartrate) is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. AMBIEN has been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see Clinical Studies (14) ] . The clinical trials performed in support of efficacy were 4–5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. AMBIEN, a gamma-aminobutyric acid (GABA) A receptor positive modulator, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. ( 1 )